WGU C204 Task 1 |Latest Update with
Complete Solution
Portfolio
A.
Attention all staff members,
The addition of Kamelon to the company's inventory is fantastic news. The pharmaceutical
industry has never been more advanced than with this brand-new product. Each one of our
clients has been waiting patiently for this for quite some time. The corporate office has been
swamped with pre-orders for this product since around the middle of February of last year. All
the sales you make on this new product as a sales team before the end of the year will earn you a
20% commission. This will be in addition to what you are already being paid. The weight loss
success rate of this brand-new product is through the roof. When you join the company's sales
force, you'll be taking on the decades-long problem of obesity in the United States. This new
medicine has an 80% success rate in men and women who weigh more than 400 pounds. When
compared to other weight reduction medications on the market, which can take up to six months
to start showing benefits, this company has a huge comparative advantage because the medicine
only needs to be administered once or twice a week to start seeing results in as little as a few
months. Strawberry and lemon are just two of the upbeat flavors that may be found in this
medication. The drug is not without its less than desired side effects. Only an inconsequential
number of test subjects experienced moderate to severe adverse effects. Not letting this deter us
from promoting and using the product is appreciated. Extremely obese people, those weighing
400 pounds or more, have been known to lose weight at such a rapid rate that their friends and
family no longer recognize them. Rapid bloating development in female patients is the drug's
, least common negative effect. Customers who report a little bloating while taking the medicine
should be advised to discontinue use and consult their physician if they hear from the sales team.
The sales staff should also ask for their current mailing address so that they can give them a free
sample of a water pill in the promotion. Employees should advise customers who are losing
weight too quickly to try cutting back on their Kamelon consumption by half per month until
their goal weight is reached.
Thank you all,
Management
B. Attention, Shareholders and Investors,
You may be aware of recent rumors concerning the possible acquisition and integration of an
outside firm known as Drug-X. I'm writing to let you know that, yes, we have indeed acquired
Drug-X, an international firm formerly situated overseas. We're absorbing their services and
incorporating them into our own to broaden our customer base and boost revenue. Drug-X's
previous manufacturer had a very restricted manufacturing process due to a lack of resources like
production machinery and skilled workers. Our organization intends to remedy this situation by
funding the purchase of new production machinery and the hiring of skilled workers at Synesthor
Inc. in Mexico. These will include state-of-the-art facilities, pill collectors, packaging, and
training. As a result of recent capital expenditure, monthly pill output is expected to increase to
at least 25,000. This has significant repercussions for the capital requirements of the business.
The costs of implementing this new company strategy have necessitated the immediate
elimination of all employee commissions and the reduction of all discretionary spending. Once
Complete Solution
Portfolio
A.
Attention all staff members,
The addition of Kamelon to the company's inventory is fantastic news. The pharmaceutical
industry has never been more advanced than with this brand-new product. Each one of our
clients has been waiting patiently for this for quite some time. The corporate office has been
swamped with pre-orders for this product since around the middle of February of last year. All
the sales you make on this new product as a sales team before the end of the year will earn you a
20% commission. This will be in addition to what you are already being paid. The weight loss
success rate of this brand-new product is through the roof. When you join the company's sales
force, you'll be taking on the decades-long problem of obesity in the United States. This new
medicine has an 80% success rate in men and women who weigh more than 400 pounds. When
compared to other weight reduction medications on the market, which can take up to six months
to start showing benefits, this company has a huge comparative advantage because the medicine
only needs to be administered once or twice a week to start seeing results in as little as a few
months. Strawberry and lemon are just two of the upbeat flavors that may be found in this
medication. The drug is not without its less than desired side effects. Only an inconsequential
number of test subjects experienced moderate to severe adverse effects. Not letting this deter us
from promoting and using the product is appreciated. Extremely obese people, those weighing
400 pounds or more, have been known to lose weight at such a rapid rate that their friends and
family no longer recognize them. Rapid bloating development in female patients is the drug's
, least common negative effect. Customers who report a little bloating while taking the medicine
should be advised to discontinue use and consult their physician if they hear from the sales team.
The sales staff should also ask for their current mailing address so that they can give them a free
sample of a water pill in the promotion. Employees should advise customers who are losing
weight too quickly to try cutting back on their Kamelon consumption by half per month until
their goal weight is reached.
Thank you all,
Management
B. Attention, Shareholders and Investors,
You may be aware of recent rumors concerning the possible acquisition and integration of an
outside firm known as Drug-X. I'm writing to let you know that, yes, we have indeed acquired
Drug-X, an international firm formerly situated overseas. We're absorbing their services and
incorporating them into our own to broaden our customer base and boost revenue. Drug-X's
previous manufacturer had a very restricted manufacturing process due to a lack of resources like
production machinery and skilled workers. Our organization intends to remedy this situation by
funding the purchase of new production machinery and the hiring of skilled workers at Synesthor
Inc. in Mexico. These will include state-of-the-art facilities, pill collectors, packaging, and
training. As a result of recent capital expenditure, monthly pill output is expected to increase to
at least 25,000. This has significant repercussions for the capital requirements of the business.
The costs of implementing this new company strategy have necessitated the immediate
elimination of all employee commissions and the reduction of all discretionary spending. Once
